Talphera (TLPH) Interest & Investment Income (2011 - 2026)
Talphera (TLPH) posted quarterly Interest & Investment Income of $169000.0 for Q1 2026, up 144.93% year-over-year from $69000.0 in Q1 2025, and down 16.75% quarter-over-quarter from $203000.0 in Q4 2025.
Talphera (TLPH) Interest & Investment Income (2011 - 2026) Analysis & Trends
Talphera's Interest & Investment Income history runs 16 years deep, the most recent figure standing at $169000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 144.93% year-over-year to $169000.0; the TTM figure through Mar 2026 stood at $536000.0 (up 1.52% YoY), while the FY2025 annual figure was $436000.0, down 35.79% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $169000.0, down from $203000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $858000.0 in Q2 2023, with the low at $38000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $147500.0 (2022), against an average of $179125.0.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income jumped 1582.35% in 2023, then tumbled 76.57% in 2024.
- Talphera's Interest & Investment Income stood at $137000.0 in 2022, then advanced by 24.82% to $171000.0 in 2023, then slumped by 39.77% to $103000.0 in 2024, then surged by 97.09% to $203000.0 in 2025, then slipped by 16.75% to $169000.0 in 2026.
- Business Quant data shows TLPH's Interest & Investment Income at $169000.0 in Q1 2026, $203000.0 in Q4 2025, and $81000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Talphera | 89.50 Mn | 89.50 Mn | - | 172,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 172,000.00 |
| Mar 31, 2026 | 169,000.00 |
| Dec 31, 2025 | 203,000.00 |
| Sep 30, 2025 | 81,000.00 |
| Jun 30, 2025 | 83,000.00 |
| Mar 31, 2025 | 69,000.00 |
| Dec 31, 2024 | 103,000.00 |
| Sep 30, 2024 | 155,000.00 |
| Jun 30, 2024 | 201,000.00 |
| Mar 31, 2024 | 220,000.00 |
| Dec 31, 2023 | 171,000.00 |
| Sep 30, 2023 | 187,000.00 |
| Jun 30, 2023 | 858,000.00 |
| Dec 31, 2022 | 137,000.00 |
| Sep 30, 2022 | 140,000.00 |
| Jun 30, 2022 | 51,000.00 |
| Mar 31, 2022 | 38,000.00 |
| Dec 31, 2021 | 32,000.00 |
| Sep 30, 2021 | 32,000.00 |
| Jun 30, 2021 | -16,000.00 |